Keyphrases
Patient Outcomes
100%
Prostate Cancer Patients
100%
Aldehyde Dehydrogenase 2 (ALDH2)
100%
Prostate Tumor Cells
100%
Prostate Cancer
45%
Normal Prostate
18%
Prostate Cancer Cells
18%
Cancer Stem Cells
18%
Immunohistochemical Analysis
9%
Solid Tumors
9%
Neuroendocrine Tumor
9%
Stem Cells
9%
Clinical Significance
9%
Cancer Tissue
9%
Overall Survival
9%
Immunohistochemistry
9%
Leukemia
9%
Outcome Prediction
9%
Associated Functions
9%
Epithelial Cells
9%
Histopathological Features
9%
Tumorigenesis
9%
Tumor Specimens
9%
Disease Outcome
9%
Gleason Score
9%
Pathological Stage
9%
New Diagnostics
9%
Clonogenic
9%
Prostate Cancer Cell Lines
9%
Specific Marker
9%
Stem Cell Population
9%
Cancer-specific Survival
9%
Approaches to Study
9%
Diagnostic Strategy
9%
Stem Cell Characteristics
9%
Human Prostate Tissue
9%
Small Populations
9%
Transplanted Tumor
9%
Prostate Cancer Outcomes
9%
Aldefluor
9%
Immunopositivity
9%
Medicine and Dentistry
Prostate Cancer
100%
Stem Cell
100%
Aldehyde Dehydrogenase
100%
Cancer Stem Cell
27%
Neoplasm
18%
Cancer Cell
18%
Disease
9%
Diagnosis
9%
Solid Malignant Neoplasm
9%
Gleason Score
9%
Neuroendocrine Tumor
9%
In Vitro
9%
Clinical Significance
9%
Prostate Cancer Cell Line
9%
Cancer Tissue
9%
Prostate Tissue
9%
Epithelial Cell
9%
Immunohistochemistry
9%
Cell Population
9%
Carcinogenesis
9%
Overall Survival
9%
Leukemia
9%
Cancer Types
9%
Cancer Specific Survival
9%
Immunology and Microbiology
Stem Cell
100%
Cancer Stem Cell
75%
Cancer Cell
50%
Mouse
25%
Overall Survival
25%
Cell Population
25%
Prostate
25%
Cancer Tissue
25%
Prostate Cancer Cell Line
25%
Prostate Tissue
25%
Gleason Score
25%
Cancer Specific Survival
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Aldehyde Dehydrogenase
100%
Malignant Neoplasm
27%
Neoplasm
18%
Disease
9%
Solid Malignant Neoplasm
9%
Gleason Score
9%
Mouse
9%
Overall Survival
9%
Carcinogenesis
9%
Leukemia
9%
Neuroendocrine Tumor
9%
Cancer Specific Survival
9%